BRIDGE: Blood Pressure Reduction and Intervention Delivery Via Group Engagement
BRIDGE
A Hybrid Type 1 Randomized Trial for Improved Post-Stroke Hypertension: This Study Aims to Examine the Impact of Group Medical Visits and Home Blood Pressure Monitoring Versus Home Blood Pressure Monitoring Alone on the the Impact of Hypertension in Those With Recent Stroke.
1 other identifier
interventional
50
1 country
1
Brief Summary
The investigators want to improve care for people who have had a stroke. High blood pressure is the leading cause for having a second stroke and can lead to poor brain health. The goal of this study is to compare two new ways of lowering blood pressure. The first way is to help people check their blood pressure at home. The second way is to bring people together and learn about blood pressure in a group setting. The study team thinks that using both methods together will make it easier to lower blood pressure after a stroke. The study team needs this study to test these two methods together in people who have had a stroke. The investigators believe this is an important study because having high blood pressure makes having another stroke very likely. Therefore, the investigators want to lower blood pressure in people with strokes to keep their brains as healthy as possible and to help with stroke recovery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable stroke
Started Sep 2025
Typical duration for not_applicable stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 21, 2025
CompletedFirst Posted
Study publicly available on registry
July 29, 2025
CompletedStudy Start
First participant enrolled
September 22, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 30, 2028
September 25, 2025
September 1, 2025
2.4 years
July 21, 2025
September 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Systolic Blood Pressure
mean systolic blood pressure
three months
Study Arms (1)
Control
ACTIVE COMPARATORHome blood pressure monitoring alone
Interventions
This arm will receive instructions for home blood pressure monitoring but also be enrolled in group medical visits.
Eligibility Criteria
You may qualify if:
- Incident, mild to moderate, ischemic or hemorrhagic stroke (NIHSS≤15, ICH score≤3)
- history or new diagnosis of hypertension
- ability to read and speak English
- internet access
- established primary care physician at MGH
You may not qualify if:
- severe stroke (NIHSS\>15, ICH score\>3)
- discharge location to inpatient rehabilitation or skilled nursing facility
- dementia
- subjects with moderate to severe aphasia without a caregiver to consent on their behalf
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Massachusetts General Hospitallead
- American Heart Associationcollaborator
Study Sites (1)
Massachusetts General Hospital
Boston, Massachusetts, 02115, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Instructor of Neurology
Study Record Dates
First Submitted
July 21, 2025
First Posted
July 29, 2025
Study Start
September 22, 2025
Primary Completion (Estimated)
January 30, 2028
Study Completion (Estimated)
April 30, 2028
Last Updated
September 25, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share